✦ LIBER ✦

Long-term therapy with sargramostim in a patient with Crohn's disease

✍ Scribed by Alan C. Wong; Scott D. Lee

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 98 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of maintenance inflixi

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease

✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i

Immediate and long-term outcomes of cort

Immediate and long-term outcomes of corticosteroid therapy in pediatric crohn's disease patients

✍ Alfreda Krupoves; David R. Mack; Ernest G. Seidman; Colette Deslandres; Vytautas 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

Background: Although a mainstay of treatment of moderate to severe Crohn's disease (CD), corticosteroids use presents significant challenges because of large interindividual variability in response. Corticosteroid-dependence is of particular concern in children, where high rates have been reported.

How adherent to treatment with azathiopr

How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?

✍ Gerassimos J. Mantzaris; Anastasios Roussos; Chryssostomos Kalantzis; Stavroula 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

## Background: Patients with longstanding quiescent crohn's disease on azathioprine usually maintain an excellent quality of life but are also concerned about long-term safety. this may affect adherence to treatment. the aim of the present study was to assess the adherence to azathioprine in a coho

Mucosal healing predicts long-term outco

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients

Cancer in Crohn's Disease patients treat

Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study

✍ Livia Biancone; Carmelina Petruzziello; Ambrogio Orlando; Anna Kohn; Sandro Ardi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

## Background: The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term. Methods: A multic

Another anti-TNF therapy for patients wi

Another anti-TNF therapy for patients with Crohn's disease

✍ Raymond Cross 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views